We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 4.60% | 22.75 | 22.00 | 23.50 | 23.25 | 21.75 | 21.75 | 479,757 | 14:22:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 8.01 | 19.83M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/7/2018 14:59 | I don't think anyone that ticks boxes a and b will have finished buying personally. I certainly haven't and I know a couple of others that haven't either. We are well below the high from a couple of years ago and so so much further down the commercial route. Well done on the tr1 though! S | shrewdmole | |
17/7/2018 14:56 | Thanks parsnip. No idea who Kevin is, though i'd guess he is the worse of the 3 Mcgeevers. lol | slartybartfaster | |
17/7/2018 14:51 | Didn't mean to make anybody cringe sir. I could have been mistaken for a clown called Kevin though lol. Not sure one can ever say they have finished buying if they have a. the cash and b. see the opportunity/value. You'll understand I'd rather not personalise that response | parsnip1 | |
17/7/2018 14:46 | Hey parsnip. Thanks for opening up with elrico the other week. It was very interesting, i particularly enjoyed the part that made tw cringe. Have you finished buying, if i'm allowed to ask. | slartybartfaster | |
17/7/2018 14:37 | Entrance criteria was waived for Spotify. Very flexible and understanding Market, particularly when there is a large investor 'pull' | parsnip1 | |
17/7/2018 14:34 | Hasn't it gone quiet here. Trak under 80p and Opti 85p. So much for that cold winter chill. Moral of the story, be careful what you wish for, what goes around comes around. | slartybartfaster | |
17/7/2018 14:31 | So $11m is target approx £8m I think that's doable in next 12-24 months so by the time you've got a couple of big US deals done and then product intergratiin that's about right for a Nasdaq listing in 2021? My gut feeling is optimwont exist in its current form by then. Sbtx could be taken out and sweetbiotix easily. The sugars would be a bun fight to take control of that by the big globals. S | shrewdmole | |
17/7/2018 13:57 | Lol lounge is a legend x | monkeywench1 | |
17/7/2018 13:56 | £1 first stop IMO... dyor | qs99 | |
17/7/2018 13:53 | To be listed on Nasdaq you'd have to fit one of these 4 criteria and as you can see by the below OPTI would have to be already in a very good place if it was ever ready to get on Nasdaq. "Standard No. 1: Earnings The company must have aggregate pre-tax earnings in the prior three years of at least $11 million, in the prior two years at least $2.2 million, and no single year in the prior three years can have a net loss. Standard No. 2: Capitalization with Cash Flow The company must have a minimum aggregate cash flow of at least $27.5 million for the past three fiscal years, with no negative cash flow in any of those three years. In addition, its average market capitalization over the prior 12 months must be at least $550 million, and revenues in the previous fiscal year must be $110 million, minimum. Standard No. 3: Capitalization with Revenue Companies can be removed from the cash flow requirement of the second standard if its average market capitalization over the past 12 months is at least $850 million and revenues over the prior fiscal year are at least $90 million. Standard No. 4: Assets with Equity Companies can eliminate the cash flow and revenue requirements, and decrease its marketing capitalization requirements to $160 million if their total assets total at least $80 million and their stockholders' equity is at least $55 million." | woodaldo | |
17/7/2018 13:45 | It's only a matter of time IMHO | loungeact | |
17/7/2018 13:43 | Nasdaq listing would surely turbocharge the share price as the US values biotech stocks really highly! | deeppockets | |
17/7/2018 13:34 | "..this is just the beginning". Yup! | colinzeal | |
17/7/2018 13:32 | Actual Bid rising all the time... | shrewdmole | |
17/7/2018 13:30 | Interesting in that interview in the look ahead. If the pharma route gets the go ahead in the US he mentioned they may look at a Nasdaq listing...That's very interesting. So much to look forward to, this is just the beginning | woodaldo | |
17/7/2018 13:30 | lol, can't see what the dog Monkey is barking on about as he's filtered, but damn he's persistent today. Clearly very worried the share price is rising. Can't be good news for his syndicate. | loungeact | |
17/7/2018 13:24 | Keep up the great ramping chaps. | monkeywench1 | |
17/7/2018 13:18 | New interview out with SOH | woodaldo | |
17/7/2018 13:16 | Agree Shrewdmole, when you consider where we will go in the future mid eighties is still very cheap. | rafboy | |
17/7/2018 13:11 | Raf Tbh it's not a bad level for the new big players to get in at mid 80's they will be wanting good returns from here. S | shrewdmole | |
17/7/2018 13:09 | It's about to move up that's why only 1 MM on offer | shrewdmole | |
17/7/2018 13:08 | Just tried to get 5k sbtx. I couldn't get an online quote. | incanus | |
17/7/2018 13:07 | It was the 70s for me, Glam Rock and all that! | rafboy | |
17/7/2018 13:05 | Aaaahhhh the 80s - how I have missed you. | jestercat2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions